TMEFF2
Tomoregulin-2
Also known as: CT120.2, HPP1, TEFF2_HUMAN, TENB2, TPEF, TR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UIK5
- Gene
- TMEFF2
- Ensembl
- ENSG00000144339
- Chromosome
- 2
- Canonical length
- 374 aa
- Protein class
- Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
This gene encodes a member of the tomoregulin family of transmembrane proteins. This protein has been shown to function as both an oncogene and a tumor suppressor depending on the cellular context and may regulate prostate cancer cell invasion. Multiple soluble forms of this protein have been identified that arise from both an alternative splice variant and ectodomain shedding. Additionally, this gene has been found to be hypermethylated in multiple cancer types. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
Canonical amino-acid sequenceUniProt
374 residues, UniProt reviewed canonical sequence.
>Q9UIK5|TMEFF2
1 MVLWESPRQC SSWTLCEGFC WLLLLPVMLL IVARPVKLAA FPTSLSDCQT PTGWNCSGYD
61 DRENDLFLCD TNTCKFDGEC LRIGDTVTCV CQFKCNNDYV PVCGSNGESY QNECYLRQAA
121 CKQQSEILVV SEGSCATDAG SGSGDGVHEG SGETSQKETS TCDICQFGAE CDEDAEDVWC
181 VCNIDCSQTN FNPLCASDGK SYDNACQIKE ASCQKQEKIE VMSLGRCQDN TTTTTKSEDG
241 HYARTDYAEN ANKLEESARE HHIPCPEHYN GFCMHGKCEH SINMQEPSCR CDAGYTGQHC
301 EKKDYSVLYV VPGPVRFQYV LIAAVIGTIQ IAVICVVVLC ITRKCPRSNR IHRQKQNTGH
361 YSSDNTTRAS TRLILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEFF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- prostate: 34 nTPM
- hypothalamus: 23 nTPM
- hippocampal formation: 23 nTPM
- cerebral cortex: 22 nTPM
- amygdala: 21 nTPM
- midbrain: 21 nTPM
Single-cell type
- epicardial cells: 1,669 nCPM
- oligodendrocytes: 1,439 nCPM
- cardiomyocytes: 1,039 nCPM
- prostatic glandular cells: 656 nCPM
- brain inhibitory neurons: 420 nCPM
- brain excitatory neurons: 419 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 60 nTPM
- amygdala: 54 nTPM
- cerebral cortex: 50 nTPM
- basal ganglia: 50 nTPM
- hippocampal formation: 47 nTPM
- hypothalamus: 47 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- negative regulation of cell migration
- negative regulation of stress fiber assembly
- wound healing, spreading of cells
- negative regulation of integrin biosynthetic process
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEFF2 as an antibody target. Whether an autoantibody or antibody against TMEFF2 could matter depends on whether native TMEFF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEFF2 is annotated as secreted, so native TMEFF2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TMEFF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...